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Background/Aims
Gastroesophageal reflux disease (GERD) is increasing in Asian countries. Functional dyspepsia (FD) or irritable bowel syndrome 
(IBS) are also prevalent and commonly overlapped with GERD. This study was conducted to compare the proportion and risk 
factors for overlapping reflux esophagitis (RE) and non-erosive reflux disease (NERD) with functional gastrointestinal disorders 
(FGIDs).
Methods
A total of 2,388 [male, 55.9%; mean age (± SD), 43.2 years (± 8.4)] Korean subjects who underwent the upper endoscopy 
for health screening were prospectively included. The subjects were asked about demographic, medical and social history by 
using a structured questionnaire, and FD and IBS were assessed according to the Rome III criteria. 
Results 
The subjects with RE were 286 (12.0%, male 88.5%, 42.8 years) and 74 subjects had NERD (3.1%) while the prevalence of 
FD and IBS were 8.1% and 10.1%, respectively. The proportion of FD and IBS in NERD was higher than that of RE (74.3% 
vs. 10.5%, p = 0.000; 41.9% vs. 11.2%, p = 0.000, respectively). The epigastric pain syndrome (EPS) was more prevalent than 
postprandial distress syndrome in NERD. According to multiple regression analysis, high somatization score and the presence 
of FD increased the odd ratio for NERD. However, male gender and current smoker were significant risk factors for RE.
Conclusions
Compared to RE, NERD is more frequently overlapped with FD, especially EPS, and also are associated with significantly in-
creased frequency of IBS. Our data draws attention to the possibility of subgrouping FGIDs and GERD to be important in un-
derstanding the pathophysiology of these conditions.
(J Neurogastroenterol Motil 2010;16:148-156)
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Introduction
Cases of gastro-esophageal reflux disease (GERD), one of 
the most common gastrointestinal disorders in Western contries, 
is incresing in Asia.
1-4 Over 50-70% of reflux patients have typi-
cal reflux symptoms in the absence of endoscopic mucosal breaks 
and are classified as non-erosive reflux disease (NERD).
5 
Functional gastrointestinal disorders (FGIDs), such as func-
tional dyspepsia (FD) or irritable bowel syndrome (IBS) are very 
common in over 20% of the general population. Epidemiologic 
studies in Korea have demonstrated the prevalence of FD and 
IBS to be around 9.5-22.3% and 2.2-9.6%, respectively.
6 
Therefore, some degree of overlap between GERD and FGIDs 
would appear inevitable, by chance alone due to the given high 
prevalence rate. Indeed recent data show that patients with 
GERD suffer more commonly from FGIDs.
7-9
　Previous studies have suggested GERD to co-exist with 
IBS in a considerable proportion of patients.
7,8,10,11 Though past 
definitions have included heartburn as a cardinal symptom of 
dyspepsia,
12 it is neither necessary nor sufficient to diagnose 
GERD, and commonly co-occurs in patients labelled as having 
FD in clinical practice.
13 Furthermore, it is clear that patients 
with epigastric symptoms would often have symptoms that arise 
from esophagus and low gastrointestinal tract. While Rome II 
classification of FGIDs categorized sub-groups by the prominent 
symptom, it failed to identify subgroups with homogeneous un-
derlying pathophysiological mechanism.
12 The Rome III criteria 
was developed to enhance research by identifying more homoge-
neous patients for pathophysiological study, especially FD, which 
was categorized into epigastric pain syndrome (EPS) and post-
prandial distress syndrome (PDS).
14 Recent epidemologic data 
showed anxiety to be linked to meal-related symptoms, and not to 
EPS.
15 The underlying mechanisms of meal-related symptoms 
may include fundic accommodation and visceral hypersensitivity. 
Whether these abnormalities are centrally mediated and hence 
modulated by anxiety is uncertain.
The epidemiologic study regarding the overlap between 
GERD and FGIDs according to Rome III criteria needs to be 
better defined as do risk factors, which may in turn promote more 
focused pathophysiological investigations.
In this study, we aimed to determine the overlap of reflux 
esophagitis (RE) and NERD with FGIDs according to Rome 
III criteria and compare the prevalence of FGIDs and its sub-
types between RE and NERD. Our underlying goal was to de-




The study population consisted of 2,932 subjects who had 
medical check-up for health screening and agreed to participate 
in this study from September 2008 to December 2008. We ex-
cluded the subjects who had significant medical illnesses (n = 
24), chronic erosive gastritis (n = 287), peptic ulcer disease (n = 
223) and esophageal or gastric cancer (n = 5) by upper endos-
copy, and history of major abdominal surgery, except appendec-
tomy, cholecystectomy or hysterectomy (n = 5).
Finally, 2,388 subjects who responded to the questionnaires 
and underwent upper endoscopy were included in the study. The 
study protocol was approved by the Institutional Review Board of 
Ewha Womans University.
2. Questionnaires and laboratory test
The original Bowel Disease Questionnaire (BDQ) was de-
signed as a self-report instrument to measure symptoms experi-
enced over the prior year and to collect past medical history 
data.
16 The kappa statistic is a chance-corrected measure of 
agreement that represents the proportion of agreement beyond 
that which is expected by chance alone. Previous testing has 
shown the BDQ to be reliable, with a median kappa statistic for 
symptom items of 0.78 (range, 0.52-1.00). In the outpatient set-
ting, it has also been demonstrated to have adequate content, con-
struct and discriminatory validity.
17 The Korean BDQ, im-
plementing the Rome III criteria, was translated from English 
into Korean following the proposed guideline.
18 It contained 56 
gastrointestinal symptom-related items; 19 items included past 
illness, health care use, and socio-demographic variables; and a 
valid measure of non-gastrointestinal somatic complaints, the 
Somatic Symptom Checklist (SSC).
19 The modified Korean BDQ 
was validated with direct interview with the median kappa of 0.74 
(0.36-1.00).
20
We also measured the severity of fatigue and stress by using 
Modified Brief Encounter Psychosocial Instrument (BEPSI) 
and fatigue severity scale (FSS), a well validated Korean version 
of fatigue and stress scoring questionnaires.
21-23 The modified 
BEPSI consists of the 5 items on a 5-point Likert type scale; a 
sum of 5 items was divided by 5. A subject with a higher score ex-Young Wook Noh, et al
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periences more stress. The internal consistency of the scale was 
high (Cronbach’s α: 0.84). The FSS contains nine items devel-
oped to assess disabling fatigue and the Korean version was 
validated.
22,23 Item responses are measured on a 7-point Likert 
type scale ranging from strongly disagree to strongly agree. The 9 
items are combined into a total score; a lower total score indicates 
less effect of fatigue on everyday life. In this study, 5 out of 9 valid 
responses to the FSS items had to be present for the FSS total 
score to be calculated. If more than 5 item responses were miss-
ing, the FSS total score was set to be missing. 
Glucose, triglyceride, low density lipoprotein-cholesterol 
(LDL-C), high density lipoprotein cholesterol (HDL-C), total 
cholesterol, and glucose were measured using colorimetric meth-
ods by an automatic analytical instrument (Hitachi 7600-110 
Automatic analyzer, Hitachi, Tokyo, Japan).
Information about a prior risk factors included in this study is 
as follows:
1) Demographics: age and gender
2) Body mass index (BMI): based on height and weight 
which were measured by the body composition analyzer 
(InBody 720, BioSpace, Seoul, Korea). BMI was calcu-
lated as the individual’s body weight divided by the square 
of height.
3) Socioeconomic status: marital status (married vs. other) 
and educational level (college graduate or higher was cate-
gorized as highly educated).
4) History of smoking habit and alcohol use: Smoking group 
was divided into current smoker and non-smoker. Alcohol 
use was defined by drinking alcohol more than 2-3 times a 
week.
3. Definition of GERD and FGIDs
RE was defined as endoscopic esophageal mucosal break 
with or without typical symptoms of GERD according to the Los 
Angeles classification.
24 NERD was defined as having typical 
heartburn at least once a week without visible esophageal mucosal 
break on endoscopy.
25 Subjects with minimal change on endos-
copy with typical symptoms were classified as NERD. Subjects 
were classified as having IBS based upon the symptoms recorded 
in the questionnaire. IBS was defined by Rome III criteria.
26 
Definition used required recurrent abdominal pain or discomfort 
with at least 2 of the following characteristics: (1) relief with defe-
cation, (2) onset associated with a change in frequency of stool, 
and (3) onset associated with a change in form (appearance) of 
stool. The subtype of IBS was based on the predominant stool 
pattern. IBS with diarrhea (IBS-D) was defined as having loose 
(mushy) or watery stools at least 25% of the time and hard stools 
less than 25% of bowel movements. IBS with constipation 
(IBS-C) was defined as having hard or lumpy stool at least 25% 
of the time and loose (mushy) or watery stools less than 25% of 
bowel movements. Mixed IBS (IBS-M) was defined as having 
hard or lumpy stool at least 25% of bowel movements and loose 
(mushy) or watery stool at least 25% of bowel movements. 
Unclassified IBS (IBS-U) had insufficient abnormality of stool 
consistency to meet the above criteria.
A criterion of FD required one or more of the following 
symptoms: (1) bothersome postprandial fullness, (2) early sati-
ation, (3) epigastric pain, and (4) epigastric burning.
14 No evi-
dence of any structural diseases (including on upper endoscopy) 
that is likely to explain the symptom was required.
Diagnostic criteria of EPS must include all of the following: 
(1) pain or burning localized to the epigastrium of at least moder-
ate severity, at least once per week, (2) the pain to be intermittent, 
(3) not generalized or localized to other abdominal or chest re-
gions, (4) not relieved by defecation or passage of flatus, and (5) 
neither fulfilling criteria for gallbladder nor sphincter of Oddi 
disorders.
14
Diagnostic criteria of PDS must include one or both of the 
following: (1) bothersome postprandial fullness, occurring after 
ordinary-sized meals, at least once a week and (2) early satiation 
that prevents finishing a regular meal, at least once a week. All the 
criteria fulfilled for the last 3 months with symptom onset at least 
6 months prior to diagnosis.
4. Statistical methods
Statistical assessment was conducted using SPSS 16.0 (SPSS 
for Windows 16.0, SPSS Inc., Chicago, IL, USA). The con-
tinuous variables were expressed as mean ± SD. Statistical sig-
nificance was set at p ＜ 0.05. One-way ANOVA was used for 
comparison of continuous variables such as age, height, weight, 
waist, BMI, SSC score, FSS, stress score, and chemistry among 
RE, NERD, and control group. The mean values of two groups 
were compared using Student’s t test. The univariate analysis be-
tween sociodemographic features and the subtype of RE, 
NERD, and FGIDs were evaluated using the Chi-squared tests 
or the Kruskal-Wallis test. Potential predictors, including FGID 
and each subtypes, for RE vs. NERD were assessed using poly-
chotomous logistic regression analyses, and adjusted by age, gen-
der, BMI, SSC, smoking status, alcohol use, marital status, and 
education. The overall SSC score was included in the models to Overlap of GERD and FGIDs
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Table 1. Comparison of Clinical Characteristics Between Subjects With Non-erosive Reflux Disease and Reflux Esophagitis
Variables RE NERD  Reference
a 
(N = 2,388) (n = 286) (n = 74) (n = 2,028)
Age (± SD) (yr)   42.8 (± 8.4)   43.8 (± 8.5)   42.7 (± 8.8)
Male (%)   88.5   47.3   51.6
BMI (kg/m
2) (± SD)   25.1 (± 2.8)   23.9 (± 3.4)   23.5 (± 3.1)
Waist (cm) (± SD)   83.5 (± 8.8)   78.8 (± 10.0)   77.9 (± 9.5)
Current smoker (%)   57.5   25.0   26.9
Alcohol use (%)   52.4   31.6   30.0
High education
b (%)   74.7   90.0   82.4
Married (%)   87.3   90.0   83.7
SSC score (± SD)     0.5 (± 0.5)     0.9 (± 0.7)     0.5 (± 0.4)
FSS (± SD)     2.9 (± 1.2)     3.3 (± 1.2)     2.8 (± 1.3)
BEPSI score (± SD)     1.8 (± 0.7)     1.9 (± 0.7)     1.8 (± 0.7)
Headache     0.7     0.9     0.6
Insomnia     0.5     0.9     0.5
Fatigue     1.3     1.7     1.2
Dizziness     0.5     1.0     0.5
Nervousness     0.7     1.0     0.5
Hot or cold spell     0.6     0.9     0.4
Cholesterol (mg/dL) 202.3 191.5 193.1
Triglyceride (mg/dL) 145.0 110.0 109.8
LDL-C (mg/dL) 125.4 114.5 116.3
HDL-C (mg/dL)   53.8   56.8   57.2
Glucose (mg/dL)   95.5   91.8   91.0
Hiatal hernia (n)     8 (2.8%)     0 (0%)   14 (0.7%)
aReference group means non-RE or non-NERD group, 
bHigh education means graduation of college or above.
RE, reflux esophagitis; NERD, non-erosive reflux disease; BMI, body mass index; SSC, somatization symptom checklist; FSS, fatigue severity score; BEPSI, brief 
encounter psychosocial instrument; LDL-C, low density lipoprotein-cholesterol; HDL-C, high density lipoprotein-cholesterol.
adjust for the tendency to over-report symptoms. The odd ratio 
(OR) and 95% confidence intervals (CIs) were computed from 
the estimated coefficients in the regression models. 
Results
1. Demographic and clinical characteristics of patients 
with GERD
A total of 2,388 subjects were included in this study. 55.9% of 
the respondents were male with mean age (± SD) of 43.2 (± 8.4) 
years. RE was found in 286 (12.0%) and 88.5% of RE were male; 
249 (87.1% of RE subject) were diagnosed as Los Angeles (LA) 
classificaton A, 35 as LA classification B, 2 as LA classification C, 
and none had LA classification D. The number of patients with 
NERD was 74 subjects (3.1%) with mean age of 43.8 (± 8.5) 
years. Reference group meant non-RE, non-NERD group (n = 
2,028). There was no significant difference of age among these 
groups. However, there was significant association of gender 
among these groups (Table 1). The male predominance was noted 
in patients with RE and female predominance was noted in NERD 
compared to the reference group. BMI, the proportion of current 
smoker and alcohol user, serum cholesterol level, serum triglyceride 
level, and glucose level in the RE group were higher than these in 
the NERD and reference group. SSC score in NERD was greater 
than these in RE and reference group. In addition, headache, in-
somnia, fatigue, dizziness, nervousness, and hot or cold spells score 
in NERD were greater than these in RE and reference group. 
There were no significant associations FSS, BEPSI, high educa-
tion, and marital status among the three groups.
2. Prevalence of FGID and its subtype according to 
Rome III in RE and NERD
The prevalence of FD was 8.1% and IBS was 10.1%. The 
proportion of FD was higher in NERD than RE (74.3% vs. 
10.5%, p = 0.000). ESP and PDS were more significantly over-
lapped with NERD than RE, with EPS being more prevalent 
than PDS in NERD (68.9% vs. 48.6%, p ＜ 0.05) (Fig. 1).Young Wook Noh, et al
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Figure 2. The proportion of irritable bowel syndrome (IBS) and its 
subtypes are compared among reflux esophagitis (RE), non-erosive 
reflux disease (NERD), and the reference group. *RE vs. NERD, 
**NERD vs. Reference. IBS-C, constipation-predominant IBS; 
IBS-D, diarrhea-predominant IBS; IBS-M, mixed pattern of IBS; 
IBS-U, unclassified pattern of IBS.
Figure 1. The proportion of functional dyspepsia (FD) and its 
subtypes are compared among reflux esophagitis (RE), non-erosive 
reflux disease (NERD), and the reference group. *RE vs. NERD, 
**NERD vs. Reference. EPS, epigastric pain syndrome; PDS, 
postprandial distress syndrome. 
Table 2. Univariate and Multivariate Analysis for Predictors of Reflux Esophagitis 
Variable
Univariate Multivariate
OR 95% CI p-value OR 95% CI p-value
Male sex 7.2 5.00-10.50 0.000 8.8  2.50-30.30 0.001
BMI 2.3 1.80-3.00 0.000 1.1  1.00-1.20 0.051
Hiatal hernia 4.3 1.80-10.30 0.001 2.9  0.60-14.80 0.212
Current smoker 3.7 2.30-6.00 0.000 1.7  1.20-2.60 0.008
Alcohol use 2.6 1.60-4.10 0.000 1.1  0.70-2.00 0.634
FD 1.4 0.90-2.10 0.120
EPS 1.2 0.70-2.10 0.583
PDS 1.3 0.80-2.00 0.339
IBS 1.1 0.80-1.70 0.512
Waist 1.1 1.04-1.10 0.000
HDL-C 1.0 0.97-0.99 0.000
Triglyceride 1.0 1.00-1.01 0.000
Glucose 1.0 1.01-1.02 0.000
OR, odd ratio; CI, confidence interval; BMI, body mass index; FD, functional dyspepsia; EPS, epigastric pain syndrome; PDS, postprandial distress syndrome; IBS, 
irritable bowel syndrome; HDL-C, high density lipoprotein-cholesterol.
Bold style indicates statistical significance.
The most prevalent subtype was IBS-D (n = 131, 54.4%) 
while the number of subjects with IBS-C and IBS-M was 29 
(12.0%) and 25 (10.4%), respectively. Overlap of IBS and 
NERD was significantly more frequent than with RE (41.9% vs. 
11.2%, p = 0.000) and the reference group (41.9% vs. 8.8%, p 
= 0.000), however, there was no difference between RE and the 
reference group. Overlap of all categories of IBS subtypes was 
found more frequently in NERD than in RE and the reference 
group (p ＜ 0.05) (Fig. 2). 
3. Assessment of predictors for RE and NERD by 
univariate and multivariate analyses
In univariated analysis, male sex, BMI, hiatal hernia, current 
smoking, alcohol user, waist circumference, low HDL-cholester-
ol level, high cholesterol, triglyceride, and glucose level were sig-
nificant predictors for RE. The significant independent pre-
dictors of RE in multivariate analysis were male sex (OR, 8.8; 
95% CI, 2.5-30.3; p = 0.001) and current smoker (OR, 1.7; Overlap of GERD and FGIDs
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Table 3. Univariate and Multivariate Analysis for Predictors of Non-erosive Reflux Disease 
Variable
Univariate Multivariate
OR 95% CI p-value OR 95% CI p-value OR 95% CI p-value
Male sex   0.7   0.40-1.10 0.132   0.7   0.3-1.8 0.428   0.5   0.14-1.40 0.179
BMI   1.2   0.70-1.90 0.550   1.0   0.4-2.8 0.973   0.8   0.30-2.50 0.688
SSC score   4.3   2.40-7.70 0.000   1.9   0.9-4.5 0.099   2.7   1.03-7.10 0.043
FD 45.3 26.20-78.40 0.000 56.4 19.8-160.5 0.000 
IBS   7.2   4.50-11.70 0.000   1.5   0.6-4.3 0.420   1.2   0.40-4.20 0.723
EPS 84.7 48.60-147.80 0.000 82.4 25.50-266.70 0.000
PDS 19.2 11.80-31.40 0.000   2.2   0.70-7.10 0.185
IBS-C   8.8   3.50-22.30 0.000
IBS-D   3.2   1.60-6.20 0.001
IBS-M   4.4   1.20-15.10 0.018
IBS-U   8.8   4.40-17.80 0.000
Insomnia   1.6   1.20-2.20 0.005
Nervousness   1.6   1.10-2.30 0.007
Hiatal hernia   0.0   0.00-0.00 0.998
Alcohol use   0.9   0.40-2.50 0.873
Current smoker   0.7   0.30-2.00 0.537
OR, odd ratio; CI, confidence interval; BMI, body mass index; SSC, somatization symptom checklist; FD, functional dyspepsia; IBS, irritable bowel syndrome; EPS,
epigastric pain syndrome; PDS, postprandial distress syndrome; IBS-C, constipation-predominant IBS; IBS-D, diarrhea-predominant IBS; IBS-M, mixed pattern of 
IBS; IBS-U, unclassified pattern of IBS. 
Bold style indicates statistical significance.
95% CI, 1.2-2.6; p = 0.008) (Table 2).
In univariate analysis, SSC score, insomnia, nervousness, 
IBS, FD, and each subtype were statistically associated with 
NERD. However in multivariate analysis, significant predictors 
of NERD were SSC score (OR, 2.7; 95% CI, 1.03-7.10; p = 
0.043) and FD (OR, 56.4; 95% CI, 19.8-160.5; p = 0.000). 
EPS was a very strong predictor for NERD (OR, 82.4; 95% CI, 
25.5-266.7; p = 0.000), however, PDS, IBS, and subtype were 
not related with NERD in multivariate analysis (Table 3).
Discussion
The morphologic spectrum of esophageal involvement in 
GERD encompasses NERD, erosive reflux disease, and 
Barrett’s esophagus based on endoscopic findings. However, 
there is still no consensus on whether GERD represents one dis-
ease that can progress from NERD to RE and Barrett’s esoph-
agus, or whether it is a spectrum of different conditions with its 
own clinical, pathophysiologic, and endoscopic characteristics. 
Moreover, the development of new instruments and techniques, 
e.g., magnifying endoscopy, have made these arguments less 
useful.
27 However, studies evaluating the epidemiology, patho-
physiology, and treatment of GERD commonly assessed RE and 
NERD as separate groups.
28
In the present study, RE and NERD, the 2 main phenotypes 
of GERD, seem to have distinct clinical characteristics and risk 
factors. Male sex and smoking were found to be the prime risk 
factors for RE, while a predictor for NERD was high somatiza-
tion score. NERD group was more overlapped with FD and IBS 
than RE and the reference group.
Both GERD and FD are recognized as the most common 
chronic diseases of adults in developed countries. Since both have 
high prevalence in the community, some overlap should be 
expected. The previous studies reported the prevalence of overlap 
of GERD with dyspepsia around 7.5-8.4%.
7,29 Similarly, in the 
present study, prevalence of FD was more prevalent in GERD, 
especially NERD, compared with the reference group. IBS was 
found to be more frequently overlapped with NERD than with 
RE. However, we noticed IBS to be equally common in both RE 
and the reference group. The previous study reported the preva-
lence rates of IBS in GERD to range from 19 to 71%.
30 In con-
trast, the rate of IBS in the non-GERD community was only 
around 5%.
30
We demonstrated significant overlap among NERD, FD, 
IBS, and its subtypes. However, the demonstration of significant 
overlap of symptoms raised the question of whether the FGIDs Young Wook Noh, et al
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should be considered as multiple separate disorders or more as of 
a common clinical entity.
There lies a significant interest in the pathophysiology of 
NERD. Chemosensitivity may explain the heartburn in NERD. 
In animal and human studies, dilatation of the intracellular spaces 
may explain heartburn in patients with NERD within physio-
logical acid exposure.
31,32 The increased paracellular permeability 
may irritate the afferent nerve in the esophageal epithelium. It is 
also possible that visceral hypersensitivity to be an important 
pathophysiologic mechanism in IBS and FD.
33-35 Stress and psy-
chological comorbidity seem also to be another factors in the gen-
eration of symptoms in patients with NERD through brain gut 
interaction.
36 Pogromov et al.
37 analyzed the psycho-autonomic 
aspects in patients with GERD and found that patients with 
NERD were characterized by more pronounced emotional, mo-
tivational, and autonomic disorders compared to RE patients. 
The present study documented the somatization score as a sig-
nificant predictor for NERD, but not for RE. The self-reported 
insomnia and nervousness are significantly related with NERD 
and these findings are consistent with the previous study. Fass et 
al.
38 showed 68.0% of FD, 71.2% of overlap of IBS-FD, and 
50.2% of IBS to have sleep disturbances in population based 
study. Dysregulation of brain-gut interaction has been suggested 
as an important factor in the pathogenesis of IBS.
39 Especially the 
diarrhea-predominant IBS was related with autonomic nervous 
dysfunction, but independent with psychological disturbance.
39 
Putative brain gut interaction may involve in altered sleep, 
GERD, and FGID.
40
Factor analyses have demonstrated some of gastrointestinal 
symptoms to occur in a cluster suggesting a specific pathophy-
siology. Camilleri et al.
41 reported the factor analysis which cate-
gorized GI symptoms into groups reflecting GERD and dyspep-
sia with the meal-related symptom cluster. In the present study, 
EPS is a strongest predictor for NERD, not PDS. In clinical 
practice, distinguishing GERD from FD may be difficult.
42 
Studies have established that clinicians often fail to recognize typ-
ical reflux symptoms. Furthermore, GERD may mimic other 
conditions including FD.
43 The previous study presented that 
one quarter of FD without reflux symptoms had pathological 
acid exposure on the distal esophagus.
13 And, epigastric pain was 
more prevalent in dyspeptic patients with pathologic esophageal 
pH monitoring. Epigastric pain was a prominent symptom in 
dyspeptic patients who were likely to respond to proton pump 
inhibitors.
44 However, it is controversial whether these group 
could be defined as the subtypes of FD. 
However, there is a concern regarding the instability of sub-
types of FGIDs or FD subtypes. Rome II criteria failed to find 
major differences in natural histories among FD subtypes.
36 
Defining a clear distinction of these overlapping group between 
NERD and FGIDs may be important in determining the 
management. Their clinical characteristics may belong in the 
spectrum of FGIDs more appropriately than in that of GERD. 
This separation might spare these intractable patients from waste-
ful courses of potent acid suppression or surgical options.
45 
Our study has several strengths and limitations. This study 
enrolled a large sample of 2,388 study participants who under-
went upper endoscopy and validated questionnaires in health pro-
motion center. Therefore, we were able to ascertain how many 
had objective evidences of reflux disease and FD. This is our 
strong point since there are substantial proportions of organic 
disease, such as stomach cancer or Helicobacter pylori related dis-
ease in Far East Asia. However, there is a possibility of sampling 
bias, such as volunteer bias. Two third of the study subjects from 
Health Promotion Center were offered with a medical examina-
tion at workplace as a reward and only 1/3 paid  by themselves. 
Therefore, some proportion of subjects who were enrolled in 
Health Promotion Center had different exposures from general 
population. The previous study in Korea demonstrated health 
screening population have higher income and educational status 
compared with general Korean population. However, other fac-
tor such as BMI, smoking, alcohol habit, or co-morbidities were 
comparable to the background population.
44,46 These factors were 
not significantly different among RE, NERD, and the reference 
group in our study.
In conclusion, NERD is more frequently overlapped with 
FD than RE, especially with EPS, and presents with significantly 
increased frequency of IBS. This data draws attention to the pos-
sibility that subgrouping the FGIDs and GERD to be important 
in understanding the pathophysiology and management of these 
conditions.
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